CytRx Scoffs At $685K Fees Request In Shareholder Suit
Biopharmaceutical company CytRx Corp. filed a brief late Friday in Delaware Chancery Court, opposing a $685,000 attorneys' fees and expenses request from the plaintiffs in a shareholder derivative suit in which...To view the full article, register now.
Already a subscriber? Click here to view full article